The relative frequency distribution of values is shown in Figure 3A. The quantitative assessment of FKBP51 IHC positivity in the study population cases, expressed as the percentage of FKBP51-positive tumor cells, was used to determine the sensitivity and specificity of the test relative to death within the first five years from diagnosis. This evidence concerns the gene FKBP5 and neoplasm.